Breaking News Instant updates and real-time market news.

OMED

OncoMed

$9.24

-0.35 (-3.65%)

08:48
11/29/16
11/29
08:48
11/29/16
08:48

OncoMed presents data for Anti-DLL4/VEGF

OncoMed Pharmaceuticals presented initial first-in-human data from its ongoing Phase 1 clinical trials of anti-DLL4/VEGF bispecific and anti-RSPO3 antibodies in two posters at the 28th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium being held in Munich, Germany. "In these first-in-human Phase 1 trials of our anti-DLL4/VEGF bispecific and anti-RSPO3 antibodies we have accomplished the primary goal of defining the safety profiles and establishing the single-agent doses for these agents. We have also observed initial evidence of anti-tumor activity in patients treated to date," said Jakob Dupont, M.D., Chief Medical Officer of OncoMed. "Dual blockade of DLL4 and VEGF has shown synergies preclinically, and in the clinic we are seeing evidence of single-agent activity with partial responses in ovarian and uterine cancers and stable disease in about one-third of the Phase 1 patients treated. We look forward to completing these trials and, in the near future, initiating Phase 1b studies with the anti-DLL4/VEGF bispecific in combination with standard of care in ovarian and colorectal cancers."

  • 29

    Nov

  • 29

    Nov

OMED OncoMed
$9.24

-0.35 (-3.65%)

06/06/16
BMOC
06/06/16
NO CHANGE
BMOC
OncoMed data positive, says BMO Capital
BMO Capital believes that data on three of OncoMed's drugs remove the risk of their development. The firm thinks that the data could cause the company's partners, Bayer and GlaxoSmithKline, to exercise options, yielding $1034M in non-dilutive financing for OncoMed.
06/06/16
PIPR
06/06/16
NO CHANGE
Target $29
PIPR
Overweight
Piper says confidence in OncoMed increased by ASCO updates
Piper Jaffray analyst Edward Tenthoff noted that OncoMed presented new Phase Ib data from vantictumab and ipafricept at the ASCO meeting, adding that he was "particularly impressed" by early ipafricept signal in ovarian cancer. The analyst, who contends that OncoMed has a "rich pipeline" of seven cancer biotherapeutics in the clinic, keeps an Overweight rating and $29 price target on the stock.
09/22/16
HCWC
09/22/16
INITIATION
Target $20
HCWC
Buy
OncoMed initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Shaunak Deepak started OncoMed Pharmaceuticals (OMED) with a Buy rating and $20 price target. The company is entering a "year of dramatic changes" with upcoming opt-in decisions for its lead drug candidates expected from partners Celgene (CELG), Bayer (BAYRY) and GlaxoSmithKline (GSK), Deepak tells investors in a research note. The analyst believes the partnerships could payoff with long-term benefits.
11/14/16
PIPR
11/14/16
NO CHANGE
PIPR
Piper sees Biotech rally continuing into 2017, lays out five to own
Piper Jaffray analyst Edward Tenthoff expects the rally in Biotechs, following "the trifecta" of a Trump Presidential election, Republican Congress sweep and defeat of Prop 61 in California, to continue into 2017. He recommends focusing on shares of Vertex (VRTX), Regeneron (REGN), Alnylam (ALNY), Exelixis (EXEL) and OncoMed (OMED). Tenthoff has a Neutral rating on Regeneron and Overweight ratings on the other four names.

TODAY'S FREE FLY STORIES

VFC

VF Corp.

$57.14

1.35 (2.42%)

15:36
12/05/16
12/05
15:36
12/05/16
15:36
Technical Analysis
VF Corp. rises, rounding bottom pattern »

The stock is up over 2.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYGN

Myriad Genetics

$16.66

0.02 (0.12%)

15:30
12/05/16
12/05
15:30
12/05/16
15:30
Options
Vote of confidence in Myriad Genetics will result in big open interest increase »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SMTC

Semtech

$30.30

1.2 (4.12%)

15:25
12/05/16
12/05
15:25
12/05/16
15:25
Conference/Events
Semtech management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

MMI

Marcus & Millichap

$27.78

0.49 (1.80%)

15:25
12/05/16
12/05
15:25
12/05/16
15:25
Hot Stocks
Marcus & Millichap's IPA unit closes sale of Isle at Arrowhead Ranch for $42M »

Marcus & Millichap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

15:25
12/05/16
12/05
15:25
12/05/16
15:25
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

RDI

Reading International

$15.76

-0.17 (-1.07%)

15:24
12/05/16
12/05
15:24
12/05/16
15:24
Conference/Events
Reading International management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

ON

ON Semiconductor

$11.12

0.15 (1.37%)

15:22
12/05/16
12/05
15:22
12/05/16
15:22
Conference/Events
ON Semiconductor management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SUP

Superior Industries

$25.43

0.725 (2.94%)

15:20
12/05/16
12/05
15:20
12/05/16
15:20
Conference/Events
Superior Industries management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 10

    Jan

VFC

VF Corp.

$57.11

1.315 (2.36%)

15:20
12/05/16
12/05
15:20
12/05/16
15:20
Options
5X average daily option volume in VFC driven by a three-way spread »

5X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIQ

Alliance HealthCare

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Hot Stocks
Alliance HealthCare Radiology forms partnership with Sodexo Healthcare »

Alliance HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Technical Analysis
NASDAQ market internals summary »

Volume is heavier than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STO

Statoil

$17.74

0.025 (0.14%)

, BP

BP

$35.59

0.11 (0.31%)

15:15
12/05/16
12/05
15:15
12/05/16
15:15
Periodicals
Statoil, BP, Total group awarded first block in Salina auction, Reuters says »

Mexico has awarded a…

STO

Statoil

$17.74

0.025 (0.14%)

BP

BP

$35.59

0.11 (0.31%)

TOT

Total

$48.33

0.55 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCO

Clear Channel Outdoor

$5.55

-0.1 (-1.77%)

15:10
12/05/16
12/05
15:10
12/05/16
15:10
Hot Stocks
Clear Channel Airports awarded 10-year contract extension by MNAA »

Clear Channel Airports, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.78

0.1735 (0.45%)

, INTC

Intel

$34.16

0.4 (1.18%)

15:06
12/05/16
12/05
15:06
12/05/16
15:06
Hot Stocks
AT&T launches first 5G business customer trial with Intel and Ericsson »

AT&T (T) said it has…

T

AT&T

$38.78

0.1735 (0.45%)

INTC

Intel

$34.16

0.4 (1.18%)

ERIC

Ericsson

$5.16

0.04 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

  • 14

    Dec

  • 29

    Mar

LLL

L-3 Communications

$157.70

0.47 (0.30%)

15:03
12/05/16
12/05
15:03
12/05/16
15:03
Conference/Events
L-3 Communications to host investor meeting with conference call hookup »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PARR

Par Pacific

$15.19

0.2 (1.33%)

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
Whitebox Advisors cuts Par Pacific stake to 16.4% from 18.2% »

Whitebox Advisors, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Conference/Events
U.S. Vice President Biden speaks on financial regulation »

Vice President Biden,…

GBT

Global Blood Therapeutics

$19.10

-0.1 (-0.52%)

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Conference/Events
Global Blood Therapeutics to hold a webcast »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 14

    Dec

  • 15

    Dec

  • 19

    Dec

NEWM

New Media

$15.93

-0.06 (-0.38%)

, DTSI

DTS, Inc.

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
New Media to replace DTS, Inc. in S&P 600 as of 12/5 close »

S&P SmallCap 600…

NEWM

New Media

$15.93

-0.06 (-0.38%)

DTSI

DTS, Inc.

TSRA

Tessera

$39.30

0.2 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBHC

National Bank

$29.99

0.835 (2.86%)

, ININ

Interactive Intelligence

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
National Bank to replace Interactive Intelligence in S&P 600 as of 12/5 close »

Genesys is acquiring…

NBHC

National Bank

$29.99

0.835 (2.86%)

ININ

Interactive Intelligence

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.55

0.46 (0.62%)

14:50
12/05/16
12/05
14:50
12/05/16
14:50
Hot Stocks
Belden CEO says targets long-term revenue growth 5%-7% »

Speaking during the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

IMGN

ImmunoGen

$1.88

0.11 (6.21%)

14:49
12/05/16
12/05
14:49
12/05/16
14:49
Hot Stocks
Breaking Hot Stocks news story on ImmunoGen »

ImmunoGen to submit IND…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COUP

Coupa Software

$26.29

-1.49 (-5.36%)

14:49
12/05/16
12/05
14:49
12/05/16
14:49
Options
Coupa Software options imply 19.3% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

IMGN

ImmunoGen

$1.88

0.11 (6.21%)

14:47
12/05/16
12/05
14:47
12/05/16
14:47
Hot Stocks
ImmunoGen reports preclinical data on IMGN632 presented at ASH meeting »

ImmunoGen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.